NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML

Product Information

Registration Status: Active

NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML is approved to be sold in Singapore with effective from 2020-12-15. It is marketed by INTEGA PTE LTD, with the registration number of SIN16058P.

This product contains Dinalbuphine Sebacate 75mg/ml in the form of INJECTION, SOLUTION. It is approved for INTRAMUSCULAR use.

This product is manufactured by Hsinchu Plant of UBI Pharma Inc. in TAIWAN.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Dinalbuphine Sebacate


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank